Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 205

    1.

    Clinical evaluation of autoantibodies to a novel PM/Scl peptide antigen.

    Mahler M, Raijmakers R, Dähnrich C, Blüthner M, Fritzler MJ.

    Arthritis Res Ther. 2005;7(3):R704-13. Epub 2005 Apr 1.

    PMID:
    15899056
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    PM1-Alpha ELISA: the assay of choice for the detection of anti-PM/Scl autoantibodies?

    Mahler M, Fritzler MJ.

    Autoimmun Rev. 2009 Mar;8(5):373-8. Epub 2008 Dec 25. Review.

    PMID:
    19103309
    [PubMed - indexed for MEDLINE]
    3.

    Serological and clinical characterization of anti-dsDNA and anti-PM/Scl double-positive patients.

    Mahler M, Greidinger EL, Szmyrka M, Kromminga A, Fritzler MJ.

    Ann N Y Acad Sci. 2007 Aug;1109:311-21.

    PMID:
    17785320
    [PubMed - indexed for MEDLINE]
    4.

    Novel aspects of autoantibodies to the PM/Scl complex: clinical, genetic and diagnostic insights.

    Mahler M, Raijmakers R.

    Autoimmun Rev. 2007 Aug;6(7):432-7. Epub 2007 Feb 20. Review.

    PMID:
    17643929
    [PubMed - indexed for MEDLINE]
    5.

    Identification of a SmD3 epitope with a single symmetrical dimethylation of an arginine residue as a specific target of a subpopulation of anti-Sm antibodies.

    Mahler M, Fritzler MJ, Blüthner M.

    Arthritis Res Ther. 2005;7(1):R19-29. Epub 2004 Nov 10.

    PMID:
    15642139
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    6.

    Anti-PM/Scl-100 and anti-RNA-polymerase III antibodies in scleroderma.

    Maes L, Blockmans D, Verschueren P, Westhovens R, De Beéck KO, Vermeersch P, Van den Bergh K, Burlingame RW, Mahler M, Bossuyt X.

    Clin Chim Acta. 2010 Jul 4;411(13-14):965-71. Epub 2010 Mar 25.

    PMID:
    20346932
    [PubMed - indexed for MEDLINE]
    7.

    C1D is a major autoantibody target in patients with the polymyositis-scleroderma overlap syndrome.

    Schilders G, Egberts WV, Raijmakers R, Pruijn GJ.

    Arthritis Rheum. 2007 Jul;56(7):2449-54.

    PMID:
    17599775
    [PubMed - indexed for MEDLINE]
    Free Article
    8.

    Epitope analysis of the major reactive region of the 100-kd protein of PM-Scl autoantigen.

    Ge Q, Wu Y, James JA, Targoff IN.

    Arthritis Rheum. 1996 Sep;39(9):1588-95.

    PMID:
    8814071
    [PubMed - indexed for MEDLINE]
    9.

    Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients.

    Hanke K, Brückner CS, Dähnrich C, Huscher D, Komorowski L, Meyer W, Janssen A, Backhaus M, Becker M, Kill A, Egerer K, Burmester GR, Hiepe F, Schlumberger W, Riemekasten G.

    Arthritis Res Ther. 2009;11(1):R22. Epub 2009 Feb 16.

    PMID:
    19220911
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    10.

    PM-Scl-75 is the main autoantigen in patients with the polymyositis/scleroderma overlap syndrome.

    Raijmakers R, Renz M, Wiemann C, Egberts WV, Seelig HP, van Venrooij WJ, Pruijn GJ.

    Arthritis Rheum. 2004 Feb;50(2):565-9.

    PMID:
    14872500
    [PubMed - indexed for MEDLINE]
    Free Article
    11.

    [Antinucleolar antibodies in diagnostics of antiphospholipid syndrome].

    Zabek J, Palacz A, Pyka J, Krzewska I.

    Pol Arch Med Wewn. 2008;118 Suppl:25-30. Polish.

    PMID:
    19562966
    [PubMed - indexed for MEDLINE]
    Free Article
    12.

    Mapping of epitopes recognized by PM/Scl autoantibodies with gene-fragment phage display libraries.

    Blüthner M, Bautz EK, Bautz FA.

    J Immunol Methods. 1996 Nov 13;198(2):187-98.

    PMID:
    8946014
    [PubMed - indexed for MEDLINE]
    13.

    Immunolocalization and partial characterization of a nucleolar autoantigen (PM-Scl) associated with polymyositis/scleroderma overlap syndromes.

    Reimer G, Scheer U, Peters JM, Tan EM.

    J Immunol. 1986 Dec 15;137(12):3802-8.

    PMID:
    3537125
    [PubMed - indexed for MEDLINE]
    14.

    Autoantibodies directed to novel components of the PM/Scl complex, the human exosome.

    Brouwer R, Vree Egberts WT, Hengstman GJ, Raijmakers R, van Engelen BG, Seelig HP, Renz M, Mierau R, Genth E, Pruijn GJ, van Venrooij WJ.

    Arthritis Res. 2002;4(2):134-8. Epub 2001 Nov 12.

    PMID:
    11879549
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    15.

    Antibodies to a nuclear/nucleolar antigen in patients with polymyositis overlap syndromes.

    Reichlin M, Maddison PJ, Targoff I, Bunch T, Arnett F, Sharp G, Treadwell E, Tan EM.

    J Clin Immunol. 1984 Jan;4(1):40-4.

    PMID:
    6699138
    [PubMed - indexed for MEDLINE]
    16.

    Anti-PM/Scl autoantibodies in patients without clinical polymyositis or scleroderma.

    Schnitz W, Taylor-Albert E, Targoff IN, Reichlin M, Scofield RH.

    J Rheumatol. 1996 Oct;23(10):1729-33.

    PMID:
    8895149
    [PubMed - indexed for MEDLINE]
    17.

    Humoral immunity in polymyositis/dermatomyositis.

    Targoff IN.

    J Invest Dermatol. 1993 Jan;100(1):116S-123S. Review.

    PMID:
    8423380
    [PubMed - indexed for MEDLINE]
    18.

    [Anti-Scl-70 and anti-centromere autoantibodies. Biological markers of 2 forms of systemic scleroderma].

    Johanet C, Agostini MM, Vayssairat M, Abuaf N.

    Presse Med. 1989 Feb 11;18(5):207-11. French.

    PMID:
    2522207
    [PubMed - indexed for MEDLINE]
    19.

    Immunoserological aspects of idiopathic inflammatory muscle disease.

    Rozman B, Bozic B, Kos-Golja M, Plesivcnik-Novljan M, Kveder T.

    Wien Klin Wochenschr. 2000 Aug 25;112(15-16):722-7.

    PMID:
    11020964
    [PubMed - indexed for MEDLINE]
    20.

    The association of anti-Ro52 autoantibodies with myositis and scleroderma autoantibodies.

    Frank MB, McCubbin V, Trieu E, Wu Y, Isenberg DA, Targoff IN.

    J Autoimmun. 1999 Mar;12(2):137-42.

    PMID:
    10047434
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk